Browse > Article

Cryopreservation of Mesenchymal Stem Cells by Vitrification  

Lee, Hyo-Jong (Institute of Animal Medicine, College of Veterinary Medicine)
kang, Sun-Young (Gyeongnam Wild Life Center)
Park, Se-Jin (Institute of Animal Medicine, College of Veterinary Medicine)
Lee, Seung-Yong (Institute of Animal Medicine, College of Veterinary Medicine)
Lee, Hee-Chun (Institute of Animal Medicine, College of Veterinary Medicine)
Koh, Phil-Ok (Institute of Animal Medicine, College of Veterinary Medicine)
Park, Ji-Kwon (School of Medicine, Gyeongsang National University)
Paik, Won-Young (School of Medicine, Gyeongsang National University)
Yeon, Seong-Chan (Institute of Animal Medicine, College of Veterinary Medicine)
Publication Information
Journal of Veterinary Clinics / v.28, no.4, 2011 , pp. 394-398 More about this Journal
Abstract
Mesenchymal stem cells (MSC) are pluripotent cells that can be found in umbilical cord blood from new borne babies as well as placenta, bone marrow, adipose tissue, amniotic fluid, muscle, et al. MSC are capable of renewing themselves without differentiation in long-term culture, also can be differentiated into various tissues under specific condition. Formulating a cryopreservation protocol for the MSC is required because these cells cannot survive for long periods under in vitro culture conditions and a new formulation of harmless cryoprotectant is needed for the direct injection of MSC into patients. The undifferentiated MSC were frozen with a vitrification solution of 40% ethylene glycol, 20% Ficoll-70 and 0.3M sucrose. The survival rate after thawing and their proliferation rate were examined and compared with slow rate cooling methods using dimethylsulfoxide (DMSO). The vitrification method showed high survival rate after thawing and proliferation capacity comparable to DMSO. It can be suggested that ultra-rapid cooling method by vitrification is reliable methods for long term preservation of MSC and the vitrification solution with ethylene glycol, Ficoll-70 and sucrose will be more beneficially used for direct transplantation of MSC into patients than DMSO solution.
Keywords
mesenchymal stem cells; cryopreservation; vitrification; human umbilical cord blood;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Jiang Y, Jahagirda BN, Reinhardt RL, Schwartz RE, Keene CD, Oritz-Gonzalez XR, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-49.   DOI   ScienceOn
2 Kasai M, Komi JH, Takakamo A, Tsudera H, Sakurai T and Machida T. A simple method for mouse embryo cryopreservation in a low toxicity vitrification solution, without appreciable loss of viability. J Reprod Fert 1990; 89: 91-97.   DOI
3 Lee KD, Kuo TK, Whang-Peng J, Chung YF, Lin CT, Chou SH, Chen JR, Chen YP, Lee OK. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 2004; 40: 1275-1284.   DOI   ScienceOn
4 Bosch P, Pratt SL, Stice SL. Isolation, characterization, gene modification, and nuclear reprogramming of porcine mesenchymal stem cells. Biol Reprod 2006; 74: 46-57.
5 Colleoni S, Donofrio G, Lagutina I, Duchi R, Galli C, Lazzari G. Establishment, differentiation, electroporation, viral transduction, and nuclear transfer of bovine and porcine mesenchymal stem cells. Cloning Stem Cells 2005; 7: 154-166.   DOI   ScienceOn
6 Crowe JH, Carpenter JF and Crowe LM. The role of vitrification in anhydrobiosis. Annu Rev Physiol. 1998; 60: 73-103.   DOI   ScienceOn
7 Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000; 28: 875-884.   DOI   ScienceOn
8 Erices A, Conget P and Minguel JJ. Mesenchymal progenitor cells in human umbilical cord blood, Br J Haematol 2000; 109: 235-242.   DOI   ScienceOn
9 Faast R, Harrison SJ, Beebe LF, McIlfatrick SM, Ashman RJ, Nottle MB. Use of adult mesenchymal stem cells isolated from bone marrow and blood for somatic cell nuclear transfer in pigs. Cloning Stem Cells 2006; 8: 166-173.   DOI   ScienceOn
10 Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 2004; 36: 568-584.   DOI   ScienceOn
11 Shim JS, Cho B, Kim M, Park GS, Shin JC, Hwang HK, Kim TG, Oh IH. Early apoptosis in CD 34+ cells as a potential heterogeneity in quality of cryopreserved umbilical cord blood. Br J Haematol 2006; 135: 210-213.   DOI   ScienceOn
12 Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147.   DOI
13 Zeng L, Rahrmann E, Hu Q, Lund T, Sandquist L, Felten M, O'Brien TD, Zhang J, Verfaillie C. Multipotent adult progenitor cells from swine bone marrow. Stem Cells 2006; 24: 2355-2366.   DOI   ScienceOn
14 Lee, O.K, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. Isolation of multipotent mesenchymal stem cells from umbilical cord blood, Blood 2004; 103: 1669-1675.   DOI   ScienceOn
15 Lennard AL, Jackson GH. Stem cell trnasplantation. BMJ 2000; 321: 433-437.   DOI   ScienceOn
16 McLellan MR, Day JG. Cryopreservation and freeze-drying protocols. Introduction. Methods Mol Biol 1995; 38: 1-5.
17 Ringe J, Kaps C, Burmester GR, Sittinger M. Stem cells for regenerative medicine: advances in the engineering of tissues and organs. Naturwissenschaften 2002; 89: 338-351.   DOI   ScienceOn
18 Rodrigues JP, Paraguassu-Braga FH, Carvalho L, Abdelhay E, Bouza LF, Porto LC. Evaluation of trehalose and sucrose as cryoprotectants for hematopoietic stem cells of umbilical cord blood. Cryobiology 2008; 56: 144-151.   DOI   ScienceOn
19 Gulliksson H. Additive solutions for the storage of platelets for transfusion. Transfus Med 2000; 10: 257-264.   DOI   ScienceOn
20 Ikehara S. Treatment of autoimmune diseases by hematopoietic stem cell trnasplantation. Exp Hematol 2001; 29: 661-669.   DOI   ScienceOn